Vincent Yan, Pharm D
About Vincent Yan, Pharm D
Vincent Yan, Pharm D, is the Director of New Indications Planning in Global Product & Portfolio Strategy at Novocure, with extensive experience in brand marketing and medical affairs.
Current Role at Novocure
Vincent Yan currently holds the position of Director, New Indications Planning - Global Product & Portfolio Strategy at Novocure. Based in the New York City Metropolitan Area, he is responsible for overseeing new indication planning and global product strategies within the company. His role involves strategic planning and execution to expand Novocure's portfolio into new therapeutic areas.
Previous Roles at Novocure
Before his current role, Vincent Yan served as Director, Brand Marketing at Novocure from 2020 to 2022. During this time, he was based in the New York City Metropolitan Area and focused on developing and executing brand marketing strategies. His contributions helped advance Novocure's market presence and brand recognition.
Experience in Oncology and Rare Disease Marketing
Vincent Yan previously worked as Associate Director, US Oncology and Rare Disease Marketing at AbbVie from 2019 to 2020. Located in Sunnyvale, California, he focused on marketing strategies for oncology and rare diseases. His role involved creating targeted marketing campaigns for complex therapeutic areas, highlighting his expertise in this specialized field.
Background in Medical Affairs
Vincent Yan has a robust background in medical affairs, having served as Director, Medical Affairs at Dermira, Inc. from 2017 to 2019. During his tenure in Menlo Park, California, he was responsible for medical strategy and operations. He also held a significant role at Gilead Sciences as Senior Product Manager, Rare Disease - Pulmonary Arterial Hypertension from 2015 to 2017, where he managed product strategies for rare diseases.
Educational Background
Vincent Yan has a comprehensive educational background in pharmacy and business. He holds a Pharm D degree from Rutgers University–New Brunswick and has completed Executive Education at Columbia Business School. His academic credentials are complemented by his early education at Staten Island Tech High School, which laid the foundation for his career in the pharmaceutical industry.